1,144
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Secretome derived from breast tumor cell lines alters the morphology of human umbilical vein endothelial cells

, , , , &
Pages 29-37 | Received 23 Feb 2016, Accepted 13 Aug 2016, Published online: 30 Sep 2016

References

  • Almendro V, Kim HJ, Cheng YK, Gonen M, Itzkovitz S, Argani P, et al. 2014. Genetic and phenotypic diversity in breast tumor metastases. Cancer Res 74:1338–1348.
  • Baronzio GF, Gramaglia A, Baronzio A, Freitas I. 2000. Influence of tumor microenvironment on thermoresponse: biologic and clinical implications. In: Madame Curie Bioscience Database [Internet]. Austin, TX: Landes Bioscience. Available from: http://www.ncbi.nlm.nih.gov/books/NBK6245/.
  • Bergers G, Benjamin LE. 2001. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3:401–410.
  • Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. 1999. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 237:97–132.
  • Dwyer J, Hebda JK, Le Guelte A, Galan-Moya EM, Smith SS, Azzi S, Bidere N, Gavard J. 2012. Glioblastoma cell-secreted interleukin-8 induces brain endothelial cell permeability via CXCR2. PLoS One 7:e45562. doi: 10.1371/journal.pone.0045562.
  • Finger EC, Giaccia AJ. 2010. Hipoxia, inflammation, and tumor microenvironment in metastatic disease. Cancer Metastasis Rev 29:285–293.
  • Folkman J. 1992. The role of angiogenesis in tumor growth. Semin Cancer Biol 3:65–71.
  • García-Ponce A, Citalán-Madrid AF, Velázquez-Avila M, Vargas-Robles H, Schnoor M. 2015. The role of actin-binding proteins in the control of endothelial barrier integrity. Thromb Haemost 113:20–36.
  • Gavard J. 2008. Breaking the VE-cadherin bonds. FEBS Lett 583:1–6.
  • Gebäck T, Schulz MM, Koumoutsakos P, Detmar M. 2009. TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 46:265–274.
  • Green TM, Alpaugh ML, Barsky SH, Rappa G, Lorico A. 2015. Breast cancer-derived extracellular vesicles: characterization and contribution to the metastatic phenotype. Biomed Res In 2015:634865. doi: 10.1155/2015/634865.
  • Gupta MK, Qin NY. 2003. Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol 9:1144–1155.
  • Han EC, Lee J, Ryu SW, Choi C. 2014. Tumor-conditioned Gr-1(+)CD11b(+) myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro. Biochem Biophys Res Commun 443:1218–1225.
  • Kryczek I, Lange A, Mottram P, Alvarez X, Cheng P, Hogan M, et al. 2005. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res 65:465–472.
  • Kurebayashi J. 2000. Regulation of interleukin-6 secretion from breast cancer cells and its clinical implications. Breast Cancer 7:124–129.
  • Lamalice L, Le Boeuf F, Huot J. 2007. Endothelial cell migration during angiogenesis. Circ Res 100:782–794.
  • Lassoued W, Murphy D, Tsai J, Oueslati R, Thurston G, Lee WM. 2010. Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors. Cancer Biol Ther 10:1326 –1333.
  • Le Guelte A, Dwyer J, Gavard J. 2011. Jumping the barrier: VE- cadherin, VEGF and other angiogenic modifiers in cancer. Biol Cell 103:593–605.
  • Li C, Guo S, Shi T. 2013. Role of NF-κB activation in matrix metalloproteinase 9, vascular endothelial growth factor and interleukin 8 expression and secretion in human breast cancer cells. Cell Biochem Funct 31:263–268.
  • Li J, Yang XF, Ren XH, Meng XJ, Huang HY, Zhao QH, et al. 2014a. Stable SET knockdown in breast cell carcinoma inhibits cell migration and invasion. Biochem Biophys Res Commun 453:7–12.
  • Li X, Zhao SJ, Shi HL, Qiu SP, Xie JQ, Wu H, et al. 2014b. Berberine hydrochloride IL-8 dependently inhibits invasion and IL-8-independently promotes cell apoptosis in MDA-MB-231 cells. Oncol Rep 32:2777–2788.
  • López-Marure R, Contreras PG, Dillon JS. 2011. Effects of dehydroepiandrosterone on proliferation, migration, and death of breast cancer cells. Eur J Pharmacol 660:268–274.
  • Matsuda Y, Hagio M, Ishiwata T, Nestin T. 2003. A novel angiogenesis marker and possible target for tumor angiogenesis. World J Gastroenterol 19:42–48.
  • Michel CC, Curry FE. 1999. Microvascular permeability. Physiol Rev 79:703–761.
  • Montiel-Dávalos A, Ibarra-Sánchez MJ, Ventura-Gallegos JL, Alfaro-Moreno E, López-Marure R. 2010. Oxidative stress and apoptosis are induced in human endothelial cells exposed to urban particulate matter. Toxicol In Vitro 24:135–141.
  • Nagy JA, Dvorak AM, Dvorak HF. 2012. Vascular hyperpermeability, angiogenesis, and stroma generation. Cold Spring Harb Perspect Med 2:a006544. doi: 10.1101/cshperspect.a006544.
  • Pàez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Viñals F, et al. 2009. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15:220–231.
  • Rivas V, Carmona R, Muñoz-Chápuli R, Mendiola M, Nogués L, Reglero C, et al. 2013. Developmental and tumoral vascularization is regulated by G protein-coupled receptor kinase 2. J Clin Invest 123:4714–4730.
  • Sáinz-Jaspeado M, Huertas-Martinez J, Lagares-Tena L, Martin Liberal J, Mateo-Lozano S, de Alava E, et al. 2013. EphA2-induced angiogenesis in ewing sarcoma cells works through bFGF production and is dependent on caveolin-1. PLoS One 8:e71449. doi: 10.1371/journal.pone.0071449.
  • Schnittler H, Taha M, Schnittler MO, Taha AA, Lindemann N, Seebach J. 2014. Actin filament dynamics and endothelial cell junctions: the Ying and Yang between stabilization and motion. Cell Tissue Res 355:529–543.
  • Schraufstatter IU, Chung J, Burger M. 2001. IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol 280:L1094–1103.
  • Sims JD, McCready J, Jay DG. 2011. Extracellular heat shock protein (Hsp)70 and Hsp90α assist in matrix metalloproteinase-2 activation and breast cancer cell migration and invasion. PLoS One 6:e18848. doi: 10.1371/journal.pone.0018848.
  • Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, Petrova TV, et al. 2001. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20:1223–1231.
  • Vujasinović T, Buta M, Markićević M, Nikolić-Vukosavljević D. 2006. Angiogenesis: bFGF and VEGF in breast carcinoma. Arch Oncol 14:126–130.
  • Weidner N, Semple JP, Welch WR, Folkman J. 1991. Tumor angiogenesis and metastasis – correlation in invasive breast carcinoma. N Engl J Med 324:1–8.
  • Wojciak-Stothard B, Ridley AJ. 2002. Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol 39:187–199.
  • Xia TS, Wang GZ, Ding Q, Liu XA, Zhou WB, Zhang YF, et al. 2012. Bone metastasis in a novel breast cancer mouse model containing human breast and human bone. Breast Cancer Res Treat 132:471–486.
  • Yoshida BA, Sokoloff MM, Welch DR, Rinker-Schaeffer CW. 2000. Metastasis-supressor genes: a review and perspective on an emerging field. J Natl Cancer Inst 92:1717–1730.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.